These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19755351)

  • 1. ACP Journal Club. Review: Aspirin does not reduce CV events but may reduce nonfatal stroke in peripheral artery disease.
    Mukherjee D
    Ann Intern Med; 2009 Sep; 151(6):JC3-5, JC3-4. PubMed ID: 19755351
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease.
    Farkouh ME
    Ann Intern Med; 2009 Jan; 150(2):JC1-8. PubMed ID: 19172713
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club: Review: Low BP targets do not reduce mortality or CV events in hypertension.
    McAlister FA
    Ann Intern Med; 2009 Nov; 151(10):JC5-6-7. PubMed ID: 19920264
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Adding clopidogrel to aspirin did not reduce recurrent stroke and increased bleeding in lacunar stroke.
    Manchak M; Holloway R
    Ann Intern Med; 2012 Dec; 157(12):JC6-2. PubMed ID: 23247951
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of aspirin for secondary prevention in patients with peripheral artery disease.
    Feldman DN; Moussa ID
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1203-7. PubMed ID: 19814663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors.
    Farkouh M
    Ann Intern Med; 2010 Jun; 152(12):JC6-10. PubMed ID: 20547892
    [No Abstract]   [Full Text] [Related]  

  • 7. Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease.
    Mukherjee D
    Evid Based Med; 2009 Dec; 14(6):172-3. PubMed ID: 19949175
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACP Journal Club. Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors.
    Taylor RJ
    Ann Intern Med; 2009 Feb; 150(4):JC2-6. PubMed ID: 19238604
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Glargine did not reduce CV events more than standard care in patients with dysglycemia.
    Lader E
    Ann Intern Med; 2012 Sep; 157(6):JC3-10, JC3-11. PubMed ID: 22986402
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk.
    Muñoz D; Granger CB
    Ann Intern Med; 2012 Apr; 156(8):JC4-07. PubMed ID: 22508747
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Daily multivitamin supplements did not reduce risk for major CV events over > 10 years in men.
    Fairfield KM
    Ann Intern Med; 2013 Feb; 158(4):JC8. PubMed ID: 23420255
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia.
    Lader E
    Ann Intern Med; 2012 Sep; 157(6):JC3-11. PubMed ID: 22986403
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD.
    Poirier P
    Ann Intern Med; 2009 Oct; 151(8):JC4-5. PubMed ID: 19841443
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Review: Aspirin does not reduce CHD or cancer mortality but increases bleeding.
    Rembold CM
    Ann Intern Med; 2012 Jun; 156(12):JC6-3. PubMed ID: 22711104
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Journal Club. Review: Counseling and educational methods that target multiple CV risk factors do not reduce mortality in adults without CHD.
    Patel MJ; Newby LK
    Ann Intern Med; 2011 Jun; 154(12):JC6-4. PubMed ID: 21690582
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Review: Blood pressure-lowering treatments reduce CV morbidity and mortality in patients receiving dialysis.
    Harnett J
    Ann Intern Med; 2009 Jul; 151(2):JC1-6. PubMed ID: 19620150
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events.
    Krebs P; Sherman SE
    Ann Intern Med; 2012 Aug; 157(4):JC2-2. PubMed ID: 22910956
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. B-vitamin supplements did not reduce vascular events in patients with recent stroke or TIA.
    Barer D
    Ann Intern Med; 2011 Feb; 154(4):JC2-8. PubMed ID: 21320935
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure.
    Singh V
    Ann Intern Med; 2012 Jul; 157(2):JC2-8. PubMed ID: 22801699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.